Introduction
Korean Antimicrobial Resistance Monitoring System reported in 2010 that the resistance rate of Acinetobacter baumannii against imipenem was 71.7%. Increasing requirement of surveillance for Imipenem-resistant Acinetobacter baumannii (IRAB), specifically designed to hospital-acquired infection control activities. It needs to detect IRAB more rapidly to prevent further spread on healthcare facilities.